Kansas City, Kan- Jenny Johnson, a non-smoker, was diagnosed with stage four lung cancer after a persistent cough led to tests.

Despite a grim prognosis of three to six years, she is still alive seven years later thanks to advanced testing, targeted therapy, and care at The University of Kansas Cancer Center.

Jenny's cancer had the EGFR mutation, qualifying her for targeted therapy. She continues surveillance treatment and remains active.

Lung cancer, which is the leading cause of cancer death, is often undetected until late stages.  

Jenny Johnson, patient

• Jenny describes her initial reaction to the diagnosis, expressing shock and disbelief.
• She shares her feelings of not belonging in the cancer center and the emotional impact of the diagnosis.
• Jenny shares her plans to start playing golf again and her overall well-being.

Dr. Krishna Reddy, Radiation Oncologist, The University of Kansas Cancer Center

• Dr. Reddy explains the evolution of radiation therapy and its role in treating metastatic cancer.
• She explains the eligibility criteria for lung cancer screening and the benefits of low-dose CT scans.

Dr. Chao Huang, Medical Oncologist, The University of Kansas Cancer Center

• Dr. Huang discusses the impact of genetic mutations like EGFR on lung cancer treatment.
• He explains the differences in lung cancer screening recommendations for smokers and non-smokers.